SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is surging on reports of a groundbreaking partnership with Novo Nordisk to sell obesity drugs, ending a prior feud. This unexpected alliance, announced late Friday, has fueled immense speculation about a massive short squeeze, leaving a highly shorted float vulnerable and sparking widespread bullish sentiment.

Innodata, Inc. is a data engineering company, which engages in providing artificial intelligence software platforms and management of its services. It operates through the following business segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment combines deep neural networks and human expertise in multiple domains to make unstructured information useable. The Synodex segment enables clients in the insurance and healthcare sectors to transform medical records into useable digital data and to apply technologies to the digital data to augment decision support. The Agility segment provides tools and related professional services that enable public relations and communications professionals to discover influencers, amplify messages, monitor coverage, and measure the impact of campaigns. The company was founded by Todd H. Solomon in 1988 and is headquartered in Ridgefield Park, NJ.

Innodata Inc

Innodata Inc. is trending as it approaches its Q4 earnings report, with community discussion centered on its strategic shift into Physical AI and Humanoid Robotics, coupled with aggressive recruitment and potential defense contracts. Investors are closely monitoring for growth acceleration, robust financial performance, and any emerging M&A speculation.

Memecoin on Cronos launched by the Cro Crow community

crow with knife

Crow with Knife ($CAW) is trending as its dedicated community highlights its fully decentralized nature, multichain expansion across major ecosystems like Solana and Base, and a deflationary burn mechanism. The token's active 'cult' of holders is buzzing about ongoing development, significant partnerships, and its perceived utility, making it a prominent discussion point among meme coin enthusiasts.

Brand Engagement Network, Inc. engages in the provision of conversational artificial intelligence assistants with the purpose of transforming engagement and analytics for businesses through security-focused, multimodal communication and human-like artificial intelligence assistants. The firm is also involved in delivering highly personalized, multi-modal artificial intelligence engagement with a focus on industries where there is a massive workforce gap and an opportunity to transform how consumers engage with networks, providers, and brands. The company is founded on March 14, 2024 and is headquartered in Jackson, WY.

Brand Engagement Network Inc

An AI licensing partnership for Brand Engagement Network's conversational AI in African markets is driving conversation around a significant short squeeze setup. Community discussion points to extremely high borrow rates and a tight float, with many seeing buying opportunities amid market volatility and its resilience in a challenging environment.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as the community celebrates the imminent departure of a prominent FDA official, widely seen as a significant barrier to the approval of its Duchenne Muscular Dystrophy therapy, Deramiocel. This development, coupled with high anticipation for a late-breaking Phase 3 data presentation at a major medical conference next week, is fueling intense bullish sentiment and expectations for a rapid regulatory decision.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull (BULL) is seeing heavy discussion following its Q4 earnings, where a clarified EPS figure and strong revenue growth were overshadowed by continued stock price declines. Community sentiment is sharply divided between frustration with dilution and management, and conviction that the fintech stock is fundamentally undervalued despite its persistent fall.

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.

uniQure N.V.

uniQure NV

uniQure (QURE) is trending due to news that a prominent FDA official, previously seen as a hurdle for gene therapies like AMT-130, is stepping down, which has ignited speculation among investors about a potentially more favorable regulatory path. This has led to a significant surge in the stock, as the community debates whether this change, following prior FDA rejection of uniQure's clinical data, will genuinely derisk its Huntington's disease treatment or if the enthusiasm is overblown.

Vertiv Holdings Co. engages in the design, manufacture, and service of critical digital infrastructure technology for data centers, communication networks, and commercial and industrial environments. It also offers power management products, switchgear and busbar products, thermal management products, integrated rack systems, modular solutions, and management systems for monitoring and controlling digital infrastructure. It operates through the following geographical segments: Americas, Asia Pacific, and Europe, Middle East, and Africa (EMEA). The Americas segment offers products and services sold for applications within the data center, communication networks, and commercial and industrial markets in North America and Latin America. The Asia Pacific segment includes products and services sold for applications within the data center, communication networks, and commercial or industrial markets throughout Greater China, Australia and New Zealand, Southeast Asia, and India. The EMEA segment focuses on products and services sold for applications within the data center, communication networks, and commercial and industrial markets in Europe, Middle East, and Africa. The company was founded in 1946 and is headquartered in Columbus, OH.

Vertiv Holdings Co - Ordinary Shares - Class A

Vertiv Holdings Co

Vertiv Holdings is trending due to its upcoming inclusion in the S&P 500 index, expected to drive significant passive fund buying. This elevation underscores its strong position as a key provider of cooling and power infrastructure for the rapidly expanding AI and data center markets, sparking community discussions about sustained growth despite some near-term profit-taking.

SPDR Series Trust - State Street SPDR S&P Biotech ETF

SPDR S&P Biotech ETF

XBI is trending as the biotech sector gains optimism from news regarding a key FDA official's departure and the Supreme Court striking down pharmaceutical tariffs, which the community believes will provide significant relief and foster further M&A activity.

ProShares Trust - ProShares Ultra VIX Short-Term Futures ETF 1.5x Shares

ProShares Ultra VIX Short-Term Futures ETF

Escalating global geopolitical tensions and oil market uncertainty are driving intense community discussion around the ProShares Ultra VIX Short-Term Futures ETF, as traders fiercely debate the timing of potential volatility spikes against the instrument's inherent decay.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Freeline Therapeutics Holdings Plc engages in the business of developing and commercializing gene therapies. It also develops gene therapies for bleeding and other debilitating disorders. The company was founded by Markus Hörer and Amit Chunilal Nathwani in 2015 and is headquartered in Stevenage, the United Kingdom.

FRLN
Freeline Therapeutics Holdings plc - ADR

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest FRLN News

FRLNFreeline Therapeutics Holdings plc - ADR